106 related articles for article (PubMed ID: 26118387)
1. Homocysteine elicits an M1 phenotype in murine macrophages through an EMMPRIN-mediated pathway.
Winchester LJ; Veeranki S; Givvimani S; Tyagi SC
Can J Physiol Pharmacol; 2015 Jul; 93(7):577-84. PubMed ID: 26118387
[TBL] [Abstract][Full Text] [Related]
2. Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway.
Fan Y; Meng S; Wang Y; Cao J; Wang C
Int J Mol Med; 2011 Apr; 27(4):607-15. PubMed ID: 21327328
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine enhances MMP-9 production in murine macrophages via ERK and Akt signaling pathways.
Lee SJ; Lee YS; Seo KW; Bae JU; Kim GH; Park SY; Kim CD
Toxicol Appl Pharmacol; 2012 Apr; 260(1):89-94. PubMed ID: 22326992
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma.
Ge H; Zhang JF; Guo BS; He Q; Wang BY; He B; Wang CQ
Vascul Pharmacol; 2007 Feb; 46(2):114-21. PubMed ID: 17055343
[TBL] [Abstract][Full Text] [Related]
5. [Resveratrol inhibits expression of EMMPRIN from macrophages].
Ge H; Zhang JF; Guo BS; He B; Wang BY; Wang CQ
Yao Xue Xue Bao; 2006 Jul; 41(7):625-30. PubMed ID: 17007354
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin.
Abe N; Osanai T; Fujiwara T; Kameda K; Matsunaga T; Okumura K
Life Sci; 2006 Jan; 78(9):1021-8. PubMed ID: 16182316
[TBL] [Abstract][Full Text] [Related]
7. Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes.
Winchester L; Veeranki S; Givvimani S; Tyagi SC
Can J Physiol Pharmacol; 2014 Jul; 92(7):575-82. PubMed ID: 24923386
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms.
Sluijter JP; Pulskens WP; Schoneveld AH; Velema E; Strijder CF; Moll F; de Vries JP; Verheijen J; Hanemaaijer R; de Kleijn DP; Pasterkamp G
Stroke; 2006 Jan; 37(1):235-9. PubMed ID: 16339461
[TBL] [Abstract][Full Text] [Related]
9. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
Rucci N; Millimaggi D; Mari M; Del Fattore A; Bologna M; Teti A; Angelucci A; Dolo V
Cancer Res; 2010 Aug; 70(15):6150-60. PubMed ID: 20631064
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
11. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation.
Seizer P; Schönberger T; Schött M; Lang MR; Langer HF; Bigalke B; Krämer BF; Borst O; Daub K; Heidenreich O; Schmidt R; Lindemann S; Herouy Y; Gawaz M; May AE
Atherosclerosis; 2010 Mar; 209(1):51-7. PubMed ID: 19758589
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of murine alternatively activated macrophages.
Weisser SB; McLarren KW; Kuroda E; Sly LM
Methods Mol Biol; 2013; 946():225-39. PubMed ID: 23179835
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells.
Zhang J; Ge H; Wang C; Guo TB; He Q; Shao Q; Fan Y
Int J Cardiol; 2007 May; 117(3):373-80. PubMed ID: 16860414
[TBL] [Abstract][Full Text] [Related]
14. Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-κB pathway.
Fan Y; Wang J; Wei L; He B; Wang C; Wang B
Int J Cardiol; 2011 Oct; 152(1):49-55. PubMed ID: 20674992
[TBL] [Abstract][Full Text] [Related]
15. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
[TBL] [Abstract][Full Text] [Related]
16. Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes.
Yuan W; Ge H; He B
Atherosclerosis; 2010 Dec; 213(2):415-21. PubMed ID: 21035802
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes.
Siwik DA; Kuster GM; Brahmbhatt JV; Zaidi Z; Malik J; Ooi H; Ghorayeb G
J Mol Cell Cardiol; 2008 Jan; 44(1):210-7. PubMed ID: 17869266
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization.
Lavin B; Gómez M; Pello OM; Castejon B; Piedras MJ; Saura M; Zaragoza C
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1739-46. PubMed ID: 24925976
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.
Gabison EE; Mourah S; Steinfels E; Yan L; Hoang-Xuan T; Watsky MA; De Wever B; Calvo F; Mauviel A; Menashi S
Am J Pathol; 2005 Jan; 166(1):209-19. PubMed ID: 15632013
[TBL] [Abstract][Full Text] [Related]
20. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.
Tyagi N; Gillespie W; Vacek JC; Sen U; Tyagi SC; Lominadze D
J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
